Global Cyclodextrin in Pharma Market Research Report 2023

Publication ID:

PB501235186

Publication Date:

January 10, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

Cyclodextrins are a family of cyclic oligosaccharides, consisting of a macrocyclic ring of glucose subunits joined by 伪-1,4 glycosidic bonds. Cyclodextrins are produced from starch by enzymatic conversion. They are used in food, pharmaceutical, drug delivery, and chemical industries, as well as agriculture and environmental engineering.
The global Cyclodextrin in Pharma market was valued at US$ 36 million in 2022 and is anticipated to reach US$ 53 million by 2029, witnessing a CAGR of 6.7% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key manufacturers of cyclodextrin in pharma include Wacker, Ensuiko Sugar Refining, Ashland, etc. Global top 3 manufacturers hold a share above 60%. Europe and North America are the major producing regions in the world, followed by China and Japan. In terms of application, the product is most widely used in tablets and capsules, followed by injectables.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cyclodextrin in Pharma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cyclodextrin in Pharma.
The Cyclodextrin in Pharma market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cyclodextrin in Pharma market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cyclodextrin in Pharma manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Wacker
Ensuiko Sugar Refining
Nihon Shokuhin Kako
Roquette
Ashland
Shandong Xinda
Yunan Yongguang
Qufu Tianli
Zibo Qianhui
Jiangsu Fengyuan
Mengzhou Huaxing
Mengzhou Hongji
Segment by Type
Alpha-Cyclodextrin in Pharma
Beta-Cyclodextrin in Pharma
Gamma-Cyclodextrin in Pharma
CD Derivatives
Segment by Application
Tablets and Capsules
Injectables
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cyclodextrin in Pharma manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Cyclodextrin in Pharma by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Cyclodextrin in Pharma in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Cyclodextrin in Pharma Market Overview
1.1 Product Definition
1.2 Cyclodextrin in Pharma Segment by Type
1.2.1 Global Cyclodextrin in Pharma Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Alpha-Cyclodextrin in Pharma
1.2.3 Beta-Cyclodextrin in Pharma
1.2.4 Gamma-Cyclodextrin in Pharma
1.2.5 CD Derivatives
1.3 Cyclodextrin in Pharma Segment by Application
1.3.1 Global Cyclodextrin in Pharma Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Tablets and Capsules
1.3.3 Injectables
1.4 Global Market Growth Prospects
1.4.1 Global Cyclodextrin in Pharma Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Cyclodextrin in Pharma Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Cyclodextrin in Pharma Production Estimates and Forecasts (2018-2029)
1.4.4 Global Cyclodextrin in Pharma Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Cyclodextrin in Pharma Production Market Share by Manufacturers (2018-2023)
2.2 Global Cyclodextrin in Pharma Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Cyclodextrin in Pharma, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Cyclodextrin in Pharma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Cyclodextrin in Pharma Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Cyclodextrin in Pharma, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Cyclodextrin in Pharma, Product Offered and Application
2.8 Global Key Manufacturers of Cyclodextrin in Pharma, Date of Enter into This Industry
2.9 Cyclodextrin in Pharma Market Competitive Situation and Trends
2.9.1 Cyclodextrin in Pharma Market Concentration Rate
2.9.2 Global 5 and 10 Largest Cyclodextrin in Pharma Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Cyclodextrin in Pharma Production by Region
3.1 Global Cyclodextrin in Pharma Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Cyclodextrin in Pharma Production Value by Region (2018-2029)
3.2.1 Global Cyclodextrin in Pharma Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Cyclodextrin in Pharma by Region (2024-2029)
3.3 Global Cyclodextrin in Pharma Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Cyclodextrin in Pharma Production by Region (2018-2029)
3.4.1 Global Cyclodextrin in Pharma Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Cyclodextrin in Pharma by Region (2024-2029)
3.5 Global Cyclodextrin in Pharma Market Price Analysis by Region (2018-2023)
3.6 Global Cyclodextrin in Pharma Production and Value, Year-over-Year Growth
3.6.1 North America Cyclodextrin in Pharma Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Cyclodextrin in Pharma Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Cyclodextrin in Pharma Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Cyclodextrin in Pharma Production Value Estimates and Forecasts (2018-2029)
4 Cyclodextrin in Pharma Consumption by Region
4.1 Global Cyclodextrin in Pharma Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Cyclodextrin in Pharma Consumption by Region (2018-2029)
4.2.1 Global Cyclodextrin in Pharma Consumption by Region (2018-2023)
4.2.2 Global Cyclodextrin in Pharma Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Cyclodextrin in Pharma Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Cyclodextrin in Pharma Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Cyclodextrin in Pharma Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Cyclodextrin in Pharma Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Cyclodextrin in Pharma Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Cyclodextrin in Pharma Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Cyclodextrin in Pharma Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Cyclodextrin in Pharma Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Cyclodextrin in Pharma Production by Type (2018-2029)
5.1.1 Global Cyclodextrin in Pharma Production by Type (2018-2023)
5.1.2 Global Cyclodextrin in Pharma Production by Type (2024-2029)
5.1.3 Global Cyclodextrin in Pharma Production Market Share by Type (2018-2029)
5.2 Global Cyclodextrin in Pharma Production Value by Type (2018-2029)
5.2.1 Global Cyclodextrin in Pharma Production Value by Type (2018-2023)
5.2.2 Global Cyclodextrin in Pharma Production Value by Type (2024-2029)
5.2.3 Global Cyclodextrin in Pharma Production Value Market Share by Type (2018-2029)
5.3 Global Cyclodextrin in Pharma Price by Type (2018-2029)
6 Segment by Application
6.1 Global Cyclodextrin in Pharma Production by Application (2018-2029)
6.1.1 Global Cyclodextrin in Pharma Production by Application (2018-2023)
6.1.2 Global Cyclodextrin in Pharma Production by Application (2024-2029)
6.1.3 Global Cyclodextrin in Pharma Production Market Share by Application (2018-2029)
6.2 Global Cyclodextrin in Pharma Production Value by Application (2018-2029)
6.2.1 Global Cyclodextrin in Pharma Production Value by Application (2018-2023)
6.2.2 Global Cyclodextrin in Pharma Production Value by Application (2024-2029)
6.2.3 Global Cyclodextrin in Pharma Production Value Market Share by Application (2018-2029)
6.3 Global Cyclodextrin in Pharma Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Wacker
7.1.1 Wacker Cyclodextrin in Pharma Corporation Information
7.1.2 Wacker Cyclodextrin in Pharma Product Portfolio
7.1.3 Wacker Cyclodextrin in Pharma Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Wacker Main Business and Markets Served
7.1.5 Wacker Recent Developments/Updates
7.2 Ensuiko Sugar Refining
7.2.1 Ensuiko Sugar Refining Cyclodextrin in Pharma Corporation Information
7.2.2 Ensuiko Sugar Refining Cyclodextrin in Pharma Product Portfolio
7.2.3 Ensuiko Sugar Refining Cyclodextrin in Pharma Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Ensuiko Sugar Refining Main Business and Markets Served
7.2.5 Ensuiko Sugar Refining Recent Developments/Updates
7.3 Nihon Shokuhin Kako
7.3.1 Nihon Shokuhin Kako Cyclodextrin in Pharma Corporation Information
7.3.2 Nihon Shokuhin Kako Cyclodextrin in Pharma Product Portfolio
7.3.3 Nihon Shokuhin Kako Cyclodextrin in Pharma Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Nihon Shokuhin Kako Main Business and Markets Served
7.3.5 Nihon Shokuhin Kako Recent Developments/Updates
7.4 Roquette
7.4.1 Roquette Cyclodextrin in Pharma Corporation Information
7.4.2 Roquette Cyclodextrin in Pharma Product Portfolio
7.4.3 Roquette Cyclodextrin in Pharma Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Roquette Main Business and Markets Served
7.4.5 Roquette Recent Developments/Updates
7.5 Ashland
7.5.1 Ashland Cyclodextrin in Pharma Corporation Information
7.5.2 Ashland Cyclodextrin in Pharma Product Portfolio
7.5.3 Ashland Cyclodextrin in Pharma Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Ashland Main Business and Markets Served
7.5.5 Ashland Recent Developments/Updates
7.6 Shandong Xinda
7.6.1 Shandong Xinda Cyclodextrin in Pharma Corporation Information
7.6.2 Shandong Xinda Cyclodextrin in Pharma Product Portfolio
7.6.3 Shandong Xinda Cyclodextrin in Pharma Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Shandong Xinda Main Business and Markets Served
7.6.5 Shandong Xinda Recent Developments/Updates
7.7 Yunan Yongguang
7.7.1 Yunan Yongguang Cyclodextrin in Pharma Corporation Information
7.7.2 Yunan Yongguang Cyclodextrin in Pharma Product Portfolio
7.7.3 Yunan Yongguang Cyclodextrin in Pharma Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Yunan Yongguang Main Business and Markets Served
7.7.5 Yunan Yongguang Recent Developments/Updates
7.8 Qufu Tianli
7.8.1 Qufu Tianli Cyclodextrin in Pharma Corporation Information
7.8.2 Qufu Tianli Cyclodextrin in Pharma Product Portfolio
7.8.3 Qufu Tianli Cyclodextrin in Pharma Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Qufu Tianli Main Business and Markets Served
7.7.5 Qufu Tianli Recent Developments/Updates
7.9 Zibo Qianhui
7.9.1 Zibo Qianhui Cyclodextrin in Pharma Corporation Information
7.9.2 Zibo Qianhui Cyclodextrin in Pharma Product Portfolio
7.9.3 Zibo Qianhui Cyclodextrin in Pharma Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Zibo Qianhui Main Business and Markets Served
7.9.5 Zibo Qianhui Recent Developments/Updates
7.10 Jiangsu Fengyuan
7.10.1 Jiangsu Fengyuan Cyclodextrin in Pharma Corporation Information
7.10.2 Jiangsu Fengyuan Cyclodextrin in Pharma Product Portfolio
7.10.3 Jiangsu Fengyuan Cyclodextrin in Pharma Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Jiangsu Fengyuan Main Business and Markets Served
7.10.5 Jiangsu Fengyuan Recent Developments/Updates
7.11 Mengzhou Huaxing
7.11.1 Mengzhou Huaxing Cyclodextrin in Pharma Corporation Information
7.11.2 Mengzhou Huaxing Cyclodextrin in Pharma Product Portfolio
7.11.3 Mengzhou Huaxing Cyclodextrin in Pharma Production, Value, Price and Gross Margin (2018-2023)
7.11.4 Mengzhou Huaxing Main Business and Markets Served
7.11.5 Mengzhou Huaxing Recent Developments/Updates
7.12 Mengzhou Hongji
7.12.1 Mengzhou Hongji Cyclodextrin in Pharma Corporation Information
7.12.2 Mengzhou Hongji Cyclodextrin in Pharma Product Portfolio
7.12.3 Mengzhou Hongji Cyclodextrin in Pharma Production, Value, Price and Gross Margin (2018-2023)
7.12.4 Mengzhou Hongji Main Business and Markets Served
7.12.5 Mengzhou Hongji Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Cyclodextrin in Pharma Industry Chain Analysis
8.2 Cyclodextrin in Pharma Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Cyclodextrin in Pharma Production Mode & Process
8.4 Cyclodextrin in Pharma Sales and Marketing
8.4.1 Cyclodextrin in Pharma Sales Channels
8.4.2 Cyclodextrin in Pharma Distributors
8.5 Cyclodextrin in Pharma Customers
9 Cyclodextrin in Pharma Market Dynamics
9.1 Cyclodextrin in Pharma Industry Trends
9.2 Cyclodextrin in Pharma Market Drivers
9.3 Cyclodextrin in Pharma Market Challenges
9.4 Cyclodextrin in Pharma Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Wacker
Ensuiko Sugar Refining
Nihon Shokuhin Kako
Roquette
Ashland
Shandong Xinda
Yunan Yongguang
Qufu Tianli
Zibo Qianhui
Jiangsu Fengyuan
Mengzhou Huaxing
Mengzhou Hongji

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂